AllSquare Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
AllSquare Wealth Management's XBI Position: Q1 2025 in Review
AllSquare Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 170 shares — an estimated $15.3K sold.
AllSquare Wealth Management first reported a position in XBI in Q3 2019 and held it in 20 quarters. The position peaked at $52K in Q4 2020. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.
- AllSquare Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
- AllSquare Wealth Management sold 170 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $15.3K.
- AllSquare Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 20 quarters.
- AllSquare Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $52K in Q4 2020.
- 685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.
Based on AllSquare Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.